United Capital Financial Advisors LLC Invests $1.40 Million in Astera Labs, Inc. $ALAB

United Capital Financial Advisors LLC bought a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) during the 2nd quarter, Holdings Channel.com reports. The firm bought 2,893 shares of the company’s stock, valued at approximately $1,397,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. BlackRock Inc. purchased a new position in shares of Astera Labs during the 2nd quarter worth about $6,609,581,000. Atreides Management LP grew its holdings in shares of Astera Labs by 108.9% during the 1st quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock worth $368,890,000 after purchasing an additional 1,754,593 shares during the period. State Street Corp increased its position in Astera Labs by 32.5% during the 4th quarter. State Street Corp now owns 3,099,809 shares of the company’s stock worth $515,684,000 after purchasing an additional 760,358 shares in the last quarter. Geode Capital Management LLC increased its position in Astera Labs by 4.5% during the 4th quarter. Geode Capital Management LLC now owns 2,429,078 shares of the company’s stock worth $403,598,000 after purchasing an additional 104,935 shares in the last quarter. Finally, Bank of America Corp DE acquired a new position in Astera Labs during the second quarter valued at approximately $1,061,791,000. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Astera Labs Stock Down 4.8%

Shares of NASDAQ ALAB opened at $289.47 on Friday. Astera Labs, Inc. has a fifty-two week low of $97.89 and a fifty-two week high of $499.48. The business has a 50 day moving average price of $342.38 and a two-hundred day moving average price of $249.65. The firm has a market cap of $50.22 billion, a PE ratio of 143.30 and a beta of 3.84.

Astera Labs (NASDAQ:ALAB) last released its earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, beating the consensus estimate of $0.69 by $0.11. The company had revenue of $392.40 million during the quarter, compared to analysts’ expectations of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The business’s revenue was up 104.5% on a year-over-year basis. During the same period in the prior year, the business posted $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, analysts anticipate that Astera Labs, Inc. will post 2.7 earnings per share for the current year.

Insider Activity

In other news, Director Jack R. Lazar sold 10,000 shares of the stock in a transaction dated Thursday, June 4th. The shares were sold at an average price of $355.17, for a total transaction of $3,551,700.00. Following the transaction, the director owned 75,688 shares of the company’s stock, valued at approximately $26,882,106.96. This trade represents a 11.67% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 136,974 shares of the business’s stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $442.01, for a total value of $60,543,877.74. Following the completion of the sale, the director directly owned 1,287,524 shares of the company’s stock, valued at approximately $569,098,483.24. This represents a 9.62% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 419,244 shares of company stock worth $163,135,169 over the last ninety days. Insiders own 10.40% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on the stock. Roth Capital reiterated a “buy” rating and set a $450.00 price objective on shares of Astera Labs in a research note on Wednesday, August 5th. Zacks Research raised shares of Astera Labs from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, August 11th. Jefferies Financial Group upped their price target on shares of Astera Labs from $270.00 to $450.00 and gave the stock a “buy” rating in a research report on Wednesday, August 5th. Morgan Stanley increased their price target on Astera Labs to $335.00 and gave the company an “overweight” rating in a report on Monday, August 3rd. Finally, Susquehanna raised their price objective on Astera Labs from $230.00 to $275.00 and gave the company a “neutral” rating in a research report on Friday, July 31st. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and eight have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $340.53.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.